The findings of a new animal study suggest that bisphosphonate treatment in donors may indeed be relevant when mineralized allografts are used in orthopaedic procedures.
Osteoporosis is the major contributor to the increasing incidence of fragility fractures associated with low-energy falls. The other contributor is the populous baby-boomer generation that
OrthoBuzz occasionally receives posts from guest bloggers. This guest post comes from Brett A. Freedman, MD. In the December 21, 2016 edition of the Journal of
Orthopaedic journals and OrthoBuzz have devoted ample space to the apparent association between long-term bisphosphonate use and atypical femoral fractures. The latest insight into this
BMJ recently published two studies of interest to orthopaedists: After analyzing data from more than 200 cardiovascular, orthopaedic, and neurologic devices approved in both the